Genomics England

Genomics England is a UK government-owned company established in 2013 to advance genomic medicine within the NHS. It was created to deliver the 100,000 Genomes Project, which successfully sequenced 100,000 whole genomes from patients with rare diseases and common cancers by 2018. This initiative aimed to integrate genomic data into routine healthcare, enhancing diagnosis, treatment, and prevention. The company collaborates with the NHS Genomic Medicine Service to provide whole genome sequencing and advanced genomic testing. It also builds and curates national genomic and health data platforms, enabling researchers to access de-identified data for medical discoveries. Genomics England focuses on transforming healthcare, accelerating research through its extensive genomic database, and ensuring data security and public trust. Its partnerships with organizations like the NHS, UK Biobank, and Illumina support its mission to improve patient outcomes and advance genomic science.